The stability studies are conducted in Year 2010. The specification for Total PRP during that time was “Not Less Than 80% of the label claim (NLT 8 mcg/SHD)”.
However, later the specifications are revised to “Not Less Than 80% of the label claim (NLT 8.8 mcg/SHD)”, as the label claim is revised to 11 mcg/SHD based on WHO recommendation.
Regarding the specification for potency of tetanus in stability studies, since the space is limited, the specification is mentioned partly.
In view of this, we are sending the Updated Stability data (Real time and Accelerated) with complete description of specifications for all tests.